Trials / Recruiting
RecruitingNCT07334366
Broccoli Sprout Extract for Cognitive Function
A 12-week Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Broccoli Sprout Extract on Cognitive Function Improvement in Adults With Mild Cognitive Impairment
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Pusan National University Yangsan Hospital · Academic / Other
- Sex
- All
- Age
- 50 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial aims to determine whether broccoli sprout extract improves cognitive function in adults with mild cognitive impairment and to assess its safety. The main questions are: * Does broccoli sprout extract improve cognitive function in participants? * What side effects occur when participants take broccoli sprout extract?
Detailed description
Researchers will compare broccoli sprout extract to a placebo to evaluate their effectiveness in improving cognitive function in participants. Participants will: * Take dietary broccoli sprout extract or a placebo daily for 12 weeks. * Visit the clinic at screenig, 0, 6, and 12 weeks for checkups and tests
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Broccoli sprout extract (BSE) | BSE 1,000 mg/day for 12 weeks |
| DIETARY_SUPPLEMENT | Placebo Control | Placebo (crystalline cellulosel) 1,000 mg/day for 12 weeks |
Timeline
- Start date
- 2025-04-16
- Primary completion
- 2026-12-30
- Completion
- 2026-12-31
- First posted
- 2026-01-12
- Last updated
- 2026-01-13
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07334366. Inclusion in this directory is not an endorsement.